Stockwatch
Axa falls 7.8% as investors sell re/insurance stocks
Insurance Day’s basket of re/insurance stocks fell 1.8% on average this week
Talanx gains 4.6% on the back of strong first-half earnings performance
German re/insurance giant’s share price has increased nearly 50% since the beginning of the year
Beazley shares tumble on growth cut
Specialty re/insurer's shares drop 13.7% this week, dragging down the Lloyd's sub-group
Hiscox shares leap 8% as share buyback extended
WTW stock back in the black for 2025 as Lloyd’s stocks outperform
RenaissanceRe shares rise on record Q2
Europeans outperform again in negative week for insurer stocks overall
Talanx and Swiss Re lead buoyant European stocks
European insurance groups rise 2.3%, as Travelers and SiriusPoint climb in mixed weeks for North American stocks
Lancashire shares surge 5% as target price raised
The Lloyd's sub-group enjoyed a strong week as re/insurance stocks fall overall
Scor, Talanx and Swiss Re lead strong performance by Europeans
Insurance Day's basket of stocks rose 1.8% on average, with European insurance groups climbing 3.8%
Insurer stocks slump 1.2% as investors cool on sector
Lloyd’s sub-group posts greatest fall, with Beazley shares down 3.4% and Hiscox losing 2.8%
European insurance stocks gain 16% in H1
Aviva and Talanx are the top-performing stocks to date, with Axa, Fairfax and SiriusPoint also posting good gains, but Lancashire has struggled
European insurance stocks tumble as Middle East fears mount
Generali and Swiss Re shares drop nearly 5%, as Hiscox continues slide from record high but Fairfax surges 5.7% amid bullish rating
Insurance stocks fall 1.9% in lacklustre week
Arch Capital stock falls 5.7% amid downgrade to hold, while Marsh McLennan and Aon shares lose more than 6%
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.